Atossa Therapeutics Stock (NASDAQ: ATOS) stock price, news, charts, stock research, profile.
You can purchase shares of Atossa Therapeutics (NASDAQ:ATOS) through any online brokerage.
Other companies in Atossa Therapeutics’s space includes: Innate Pharma (NASDAQ:IPHA), Skye Bioscience (NASDAQ:SKYE), PepGen (NASDAQ:PEPG), Adaptimmune Therapeutics (NASDAQ:ADAP) and Black Diamond Therapeutic (NASDAQ:BDTX).
Atossa Therapeutics has a consensus price target of $6.75.
The stock price for Atossa Therapeutics (NASDAQ: ATOS) is $1.18 last updated November 21, 2024 at 6:28 AM EST.
There are no upcoming dividends for Atossa Therapeutics.
Atossa Therapeutics’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Atossa Therapeutics.
Atossa Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.